COMPUTATIONAL IMMUNOLOGY RESEARCH AND DEVELOPMENT LTD
Significant control: Caddis Group Ltd (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Computational Immunology Research And Development Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Computational Immunology Research And Development Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
COMPUTATIONAL IMMUNOLOGY RESEARCH AND DEVELOPMENT LTD is an active private limited company (company number 11373361) incorporated on 21 May 2018, registered in Dereham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £0, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the lower half of 278 comparable companies in Other (median £129, upper quartile £59k).
Ownership and control
- Caddis Group Ltd
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 21 May 20188 yrs ago
- Next accounts due
- 28 February 2027in 125 days
- Confirmation statement due
- 4 June 2027in 221 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £0 | — | — | £0 | — | — | 1 |
| 31 May 2024 | £0 | — | — | £0 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £0 at 31 May 2025
- Incorporated five or more years agoIncorporated 21 May 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 221 days
- Next accounts duein 125 days
- Accounts period endNet assets £0 · micro accounts
- Accounts period endNet assets £0 · micro accounts
- Incorporated
Similar companies in the UK
- C F M D LIMITEDPeterborough · inc. May 2018
- NETHERTON INDUSTRIES LIMITEDYelverton · inc. May 2018
- VP PHARMA CONSULTANCY LTDWimborne · inc. May 2018
- NCSI CONSULTANCY LTDAylesbury · inc. Jun 2018
- PHYTOME RESEARCH LIMITEDLaunceston · inc. Jun 2018
- EUROPEAN SCIENTIFIC RESOURCES LTDWrexham · inc. Jun 2018
All companies incorporated on 21 May 2018 · in May 2018.
Reminders for COMPUTATIONAL IMMUNOLOGY RESEARCH AND DEVELOPMENT LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.